Weight-loss medications
In trials, retatrutide reached 28.7% weight loss vs Mounjaro's 22.5%. Retatrutide isn't UK-approved yet, so Mounjaro is the current option.
Weight-loss medications
Mounjaro produced more weight loss than CagriSema in REDEFINE 4: 25.5% vs 23.0% over 84 weeks. Only Mounjaro is licensed and available in the UK.
Weight-loss medications
CagriSema: 22.7% weight loss in REDEFINE 1, the highest for any Novo Nordisk obesity drug. Lost head-to-head to Mounjaro. Not yet UK-approved.
Weight-loss medications
CagriSema isn't yet available in the UK. No MHRA filing as of May 2026. Private launch likely 2026-2027, NHS access from 2028.
Wegovy compatibility
You can take Wegovy with rheumatoid arthritis. Find out how it interacts with RA medications and why weight loss may improve disease activity.
Wegovy compatibility
You can take Wegovy with chronic kidney disease. Find out which stages are safe, how to monitor, and why it may protect kidney function.
Wegovy compatibility
You can take Wegovy after a gastric band, but the combination needs medical supervision. Find out what to expect from your bariatric team and GP.
Wegovy compatibility
Wegovy is safe to take with fibromyalgia. What the evidence shows on weight loss, pain, and fatigue, plus practical guidance for managing both.
Mounjaro compatibility
Mounjaro isn't recommended in pregnancy. UK guidance, the evidence on inadvertent exposure, and how to plan stopping safely before conceiving.
Wegovy compatibility
Wegovy and pregnancy: UK guidance says stop two months before trying to conceive. What the evidence shows and how to plan it safely.
As seen on
As seen on